20/06/2024 Healthcare
Cefromin-SB 1.5 GM combines Cefoperazone and Sulbactam, offering potent antibacterial activity against severe infections. Cefoperazone, a third-generation cephalosporin, targets a wide range of gram-positive and gram-negative bacteria. Sulbactam inhibits beta-lactamase enzymes, enhancing Cefoperazone's effectiveness against resistant strains. Administered intravenously, Cefromin-SB 1.5 GM is crucial in hospital settings for treating complex infections. It provides robust therapy, addressing challenging bacterial infections and supporting positive patient outcomes in critical care scenarios.Available in PCD Franchise for injectable range and third party manufacturing.
Cefromin-SB 1.5 GM combines Cefoperazone and Sulbactam, offering potent antibacterial activity against severe infections. Cefoperazone, a third-genera...
Cefoperazone Sulbactam Injection, marketed under the brand name Triazon-SB, combines an antibiotic with a beta-lactamase inhibitor to treat severe inf...
Ciflozone-SB Injection combines Cefoperazone with Sulbactam, offering potent antibacterial action against severe infections. Cefoperazone, a third-gen...
Meropenem Sulbactam Injection, marketed as Flaxsat-S Injection, combines meropenem, a potent antibiotic, with sulbactam, a β-lactamase inhibitor. This...
More Details